Submitted by Anonymous (not verified) on 18 May 2026 - 10:33 Orphan designation: bemarituzumab Treatment of gastric cancer, 21/08/2024 Withdrawn Link: https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-24-2966Source: What's new